Japan fund backs neglected disease R&D

Save

GHIT has also provided a second round financing of $5.65m for work on a novel vaccine candidate against tuberculosis (TB) being co-developed by the National Institute of Biomedical Innovation, Japan's Create Vaccine Co and the US-based non-profit…